Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 183

The DOI matches its Crossref record.

Multidrug resistance in European Clostridium difficile clinical isolates

Spigaglia, P., Barbanti, F., Mastrantonio, P., on behalf of the European Study Group on Clostridium difficile (ESGCD), Ackermann, G., Balmelli, C., Barbut, F., Bouza, E., Brazier, J., Delmee, M., Drudy, D., Kuijper, E., Ladas, H., Mastrantonio, P., Nagy, E., Pituch, H., Poxton, I., Rupnik, M., Wullt, M., Yucesoy, M. · 2011 · Journal of Antimicrobial Chemotherapy

Abstract

OBJECTIVES: Multidrug resistance and antibiotic resistance mechanisms were investigated in 316 Clostridium difficile clinical isolates collected during the first European surveillance on C. difficile in 2005. METHODS: MICs of eight different antibiotics were determined using Etest. Reserpine- and carbonyl cyanide m-chlorophenylhydrazone-sensitive efflux was tested using the agar dilution method. Molecular analysis of the resistance mechanisms was performed using PCR assays, PCR mapping and sequencing. RESULTS: One hundred and forty-eight C. difficile strains were resistant to at least one antibiotic and 82 (55%) were multidrug resistant. In particular, 48% of these isolates were resistant to erythromycin, clindamycin, moxifloxacin and rifampicin. New genetic elements or determinants conferring resistance to erythromycin/clindamycin or tetracycline were identified. Even if most multiresistant strains carried an erm(B) gene, quite a few were erm(B) negative. In-depth analysis of the underlying mechanism in these isolates was carried out, including analysis of 23S rDNA and the ribosomal proteins L4 and L22. Interestingly, resistance to rifampicin was observed in multidrug-resistant strains in association with resistance to fluoroquinolones. Mutations in the rpo(B) and gyrA genes were identified as the cause of resistance to these antibiotics, respectively. CONCLUSIONS: Characterization of multidrug-resistant C. difficile clinical isolates shows that antibiotic resistance is changing, involving new determinants and mechanisms and providing this pathogen with potential advantages over the co-resident gut flora. The present paper provides, for the first time, a comprehensive picture of the different characteristics of multidrug-resistant C. difficile strains in Europe in 2005 and represents an important source of data for future comparative European studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jac/dkr292

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 183

Metadata

Authors
Spigaglia, P., Barbanti, F., Mastrantonio, P., on behalf of the European Study Group on Clostridium difficile (ESGCD), Ackermann, G., Balmelli, C., Barbut, F., Bouza, E., Brazier, J., Delmee, M., Drudy, D., Kuijper, E., Ladas, H., Mastrantonio, P., Nagy, E., Pituch, H., Poxton, I., Rupnik, M., Wullt, M., & Yucesoy, M.
Venue
Journal of Antimicrobial Chemotherapy
Published
2011-07-19
Volume
66
Issue
10
Pages
2227-2234
ISSN
  • 0305-7453 (ISSN-L)
  • 1460-2091
OpenAlex
W2127894127
Cited by
183
References
0
FWCI
8.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multidrug resistance in European Clostridium difficile clinical isolates. https://app.cochat.ai/papers/10.1093/jac/dkr292
The paper
Spigaglia, P., Barbanti, F., Mastrantonio, P., on behalf of the European Study Group on Clostridium difficile (ESGCD), Ackermann, G., Balmelli, C., Barbut, F., Bouza, E., Brazier, J., Delmee, M., Drudy, D., Kuijper, E., Ladas, H., Mastrantonio, P., Nagy, E., Pituch, H., Poxton, I., Rupnik, M., Wullt, M., & Yucesoy, M. (2011). Multidrug resistance in European Clostridium difficile clinical isolates. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkr292

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.